Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof

Abstract From the Canadian patent

A formulation comprising i) fenofibric acid a physiologically acceptable salt , or derivative thereof and optionally other active substances ii) a binder , component comprising at least one enteric binder and optionally iii) other , physiologically acceptable excipients is described. Fenofibric acid the , physiologically acceptable salt or derivative thereof is preferably in the form of a molecular dispersion in these formulations. An advantageous process for their preparation, in particular by melt extrusion and the use of this , formulation for oral administration of fenofibric acid a physiologically , acceptable salt or derivative thereof are likewise described.